Welcome to our dedicated page for P3 HEALTH PARTNERS news (Ticker: PIIIW), a resource for investors and traders seeking the latest updates and insights on P3 HEALTH PARTNERS stock.
P3 Health Partners Inc. reports developments tied to its physician-led population health management business and value-based care model. Company news centers on Medicare Advantage provider networks, at-risk membership, operating results, revenue outlooks, market-entry updates and investor conference participation.
The PIIIW symbol represents warrants exercisable for Class A common stock. P3’s updates also describe its use of data, technology, physician leadership and community outreach to support coordinated care, patient outcomes, provider satisfaction and lower care costs.
P3 Health Partners reported a strong revenue growth of 46% for Q4 2021 and 32% for the full year, projecting 2022 revenue up to $1 billion (a 56% increase). The company aims for 95,000 at-risk Medicare Advantage members by year-end, a 42% rise. Adjusted EBITDA is expected to improve significantly, with profitability anticipated by 2024. Despite a net loss of up to $95 million for Q4, a robust cash position of $140 million at year-end supports operations. P3 will file for a late 10-K extension, expecting to release detailed results by April 15, 2022.
P3 Health Partners, Inc. (NASDAQ: PIII), a physician-led population health management company, announced its participation in three investor conferences in March 2022. The company will present at the Cowen 42nd Annual Healthcare Conference on March 9, attend the 34th Annual ROTH Conference on March 14 in Dana Point, CA, and participate in the Barclays Global Healthcare Conference on March 16 in Miami, FL. Live webcasts will be available on P3’s investor relations website, providing access to presentations and replays.